Literature DB >> 3547491

Polycystic ovarian disease: US features in 104 patients.

H C Yeh, W Futterweit, J C Thornton.   

Abstract

Ultrasonographic (US) study was performed in 25 healthy women and 104 patients with polycystic ovarian disease (PCOD). Although the average size of ovaries in the PCOD patients was much larger than that of the healthy women, 29.7% of ovaries in the PCOD patients were normal in size. The shapes of the ovaries (roundness index) in PCOD patients were not different from those of the healthy women. There was no significant correlation between the size and shape of the ovaries. Bilaterally enlarged, globular-shaped ovaries were rare and usually asymmetric in size. The most important feature of PCOD on US scans is the bilaterally increased numbers of developing follicles (0.5-0.8 cm in size), usually more than five in each ovary. Although maturing follicles (1.5-2.9 cm) are much rarer in PCOD patients (13.5%) than in healthy women (36%), the incidences of follicular cysts (greater than 3 cm) was about the same in both.

Entities:  

Mesh:

Year:  1987        PMID: 3547491     DOI: 10.1148/radiology.163.1.3547491

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Transvaginal ultrasound in a children's hospital: is it worthwhile?

Authors:  R D Bellah; H K Rosenberg
Journal:  Pediatr Radiol       Date:  1991

2.  Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.

Authors:  Jacob P Christ; Amy D Willis; Eric D Brooks; Heidi Vanden Brink; Brittany Y Jarrett; Roger A Pierson; Donna R Chizen; Marla E Lujan
Journal:  Fertil Steril       Date:  2013-11-01       Impact factor: 7.329

3.  Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors.

Authors:  Young Shin Han; Ah Rha Lee; Hee Kyoung Song; Jeong In Choi; Jang Heub Kim; Mee Ran Kim; Min Jeong Kim
Journal:  J Menopausal Med       Date:  2017-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.